CO M M E R C I A L LO A N AG R E E M E N TCommercial Loan Agreement • March 1st, 2022 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • Utah
THIS COMMERCIAL LOAN AGREEMENT (this “Loan Agreement”), dated as of November 22, 2021, is entered into by and between NORTHWEST BIOTHERAPEUTICS, INC., a Delaware corporation (“Borrower”), and STREETERVILLE CAPITAL, LLC, a Utah limited liability company, its successors and/or assigns (“Lender”).
SUB-LEASE AGREEMENTSub-Lease Agreement • March 1st, 2022 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
This Sub-lease Agreement (“Agreement”) is made and entered into effective as of December 31, 2021 (the “Effective Date”), by and between Aracaris Ltd. (“Aracaris”), a United Kingdom (U.K.) company and Northwest Biotherapeutics, Inc. (“NWBio”), a U.S. Delaware company (Aracaris and NWBio, collectively, the “Sub-Lessor”), and Advent BioServices, Ltd. (the “Sub-Lessee”), a U.K. company.
